The role of thiazolidinediones in reversing insulin sensitivity and altering endothelial dysfunction
Clinical Trials Report
- 20 Downloads
Keywords
Insulin Resistance Rosiglitazone Myocardial Blood Flow Thiazolidinediones Troglitazone
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Hsueh WA, Law RE: Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med 1998, 105:4S-14S.PubMedCrossRefGoogle Scholar
- 2.Onat A, Hergenc G, Sari I, et al.: Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study. Am J Hypertens 2005, 18:409–416.PubMedCrossRefGoogle Scholar
- 3.Baron AD, Steinberg HO, Chaker H, et al.: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 1995, 96:786–792.PubMedGoogle Scholar
- 4.Zeng G, Nystrom FH, Ravichandran LV, et al.: Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539–1545.PubMedGoogle Scholar
- 5.Fulton D, Gratton JP, McCabe TJ, et al.: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399:597–601.PubMedCrossRefGoogle Scholar
- 6.Burant CF, Sreenan S, Hirano K, et al.: Troglitazone action is independent of adipose tissue. J Clin Invest 1997, 100:2900–2908.PubMedCrossRefGoogle Scholar
- 7.Williams B: Angiotensin II and the pathophysiology of cardiovascular remodeling. Am J Cardiol 2001, 87:10C-17C.PubMedCrossRefGoogle Scholar
- 8.Worley JR, Baugh MD, Hughes DA, et al.: Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. J Biol Chem 2003, 278:51340–51346.PubMedCrossRefGoogle Scholar
- 9.Choi S: Preventive effects of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes. Diabetes 2003, 52:A19.Google Scholar
Copyright information
© Current Science Inc. 2005